|
E2F5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.05279999999641E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.246800E-04 |
| Normal-vs-Stage2 |
1.281920E-02 |
| Normal-vs-Stage3 |
3.31360000549452E-08 |
| Normal-vs-Stage4 |
1.35249999999587E-06 |
| Stage1-vs-Stage2 |
8.044800E-01 |
| Stage1-vs-Stage3 |
3.818500E-03 |
| Stage1-vs-Stage4 |
3.856200E-02 |
| Stage2-vs-Stage3 |
2.275900E-02 |
| Stage2-vs-Stage4 |
5.802200E-02 |
| Stage3-vs-Stage4 |
9.117800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56405999999221E-05 |
| Normal-vs-AfricanAmerican |
4.881000E-03 |
| Normal-vs-Asian |
8.02800000000436E-05 |
| Caucasian-vs-AfricanAmerican |
8.984800E-01 |
| Caucasian-vs-Asian |
7.464400E-01 |
| AfricanAmerican-vs-Asian |
7.178800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5293999999777E-06 |
| Normal-vs-Female |
1.188340E-04 |
| Male-vs-Female |
2.005800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.778100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.14709999999396E-05 |
| Normal-vs-Age(61-80Yrs) |
9.10839999979096E-07 |
| Normal-vs-Age(81-100Yrs) |
1.234190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.910000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.195450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.370200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.709200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.467400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.738600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.112100E-02 |
| Classical-VS-Follicular |
5.841800E-01 |
| Classical-VS-Other |
6.366400E-01 |
| Classical-VS-Normal |
6.44159999999561E-05 |
| Tall-VS-Follicular |
1.154380E-02 |
| Tall-VS-Other |
4.905000E-01 |
| Tall-VS-Normal |
8.83210000024448E-07 |
| Follicular-VS-Other |
5.799200E-01 |
| Follicular-VS-Normal |
4.383500E-03 |
| Other-VS-Normal |
4.100000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.790200E-04 |
| Normal-vs-N1 |
3.49590023596136E-10 |
| N0-vs-N1 |
2.012300E-04 |
|
|
